UPC_CFI_407/2025

COMPOSITION COMPRISING ANTIBODY THAT BINDS TO DOMAIN II OF HER2 AND ACIDIC VARIANTS THEREOF

Procedural & sub-applicationsEvidence & InspectionBrussels LDGenericCase ClosedSettled at: Pre-merits

Overview Decisions Documents Timeline

Parties

Claimants

Genentech, Inc.(Roche Group)
F. Hoffmann-La Roche AG(Roche Group)

Reps: Rutger Kleemans (Freshfields LLP); Allard van Duijn (Freshfields LLP)

Respondents

Organon & Co
Organon Heist B.V.
N.V. Organon
Shanghai Henlius Biotech, Inc.

Reps: Andreas Kabisch (Meissner Bolte Patentanwälte Rechtsanwälte Partnerschaft mbB); Moritz-Melchior Bloser (Meissner Bolte); Julian Würmser (Meissner Bolte)

Judges

Samuel Granata
Petri Rinkinen
Rute Lopes

Patents

EP3401335
EP3353901
EP 3 401 335 B1
EP 3 401 335

CPC codes: A61P1/04, C07K2317/76, G01N27/447, G01N2030/027, C07K2317/24, C07K16/065, C07K2317/41, A61P15/00, A61P35/00, G01N30/02, C07K16/2863, A61P11/00…

Sector: Measurement & Testing

Outcome

Withdrawn

Filed: May 6, 2025

First decided: May 30, 2025

Last decision: Dec 22, 2025

Language: English

Settled at: Pre-merits

The Düsseldorf Local Division accepted the mutual withdrawal of Atlas Global Technologies' infringement action and Vantiva's counterclaim for revocation concerning EP 3 353 901, with the parties waiving a cost decision.

Open on UPC Registry